Drug Type Shared antigen vaccine |
Synonyms- |
Target |
Mechanism MAGEA1 inhibitors(Melanoma-associated antigen 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma, Cutaneous Malignant | Phase 2 | US | 01 Feb 2011 | |
Extranodal Extension | Phase 2 | US | 01 May 2004 | |
Melanoma recurrent | Phase 2 | US | 01 May 2004 | |
Metastatic melanoma | Phase 2 | US | 01 May 2004 | |
Mucosal Melanoma | Phase 2 | US | 01 May 2004 | |
stage IIB melanoma | Phase 2 | US | 01 May 2004 | |
Uveal Melanoma | Phase 2 | US | 01 May 2004 |
- | 10 | (Arm I (Vaccine Therapy)) | uoenhswrbh(xoiumfvwph) = zxvgmuyqpe ghcowdxxho (wgucheypzi, vrhcazpzoi - smueifrbgq) View more | - | 24 Oct 2016 | ||
(Arm II (Vaccine Therapy, IL-12)) | uoenhswrbh(xoiumfvwph) = ytkwufwdde ghcowdxxho (wgucheypzi, kxcftcxymp - hgldqfnmew) View more |